v3.25.2
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Jun. 28, 2025
Jun. 29, 2024
Cash flows from operating activities    
Net income $ 65,993 $ 45,794
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 11,902 10,612
Amortization of deferred financing fees 93 93
Equity-based compensation 4,978 6,090
Deferred taxes 507 (653)
Loss on disposal of property, plant, and equipment 29 43
Foreign currency transaction (gain) loss (796) 212
Equity in net loss of affiliates 585 1,343
Dividends from equity method investment 236 522
Change in fair value of contingent consideration 0 7,912
Change in assets and liabilities:    
Accounts receivable (14,910) (8,088)
Floor plan receivables (144) (10,603)
Inventories 5,450 (1,375)
Other assets (4,333) 5,541
Accounts payable 2,697 10,950
Accrued expenses and other liabilities 3,015 16,223
Net cash provided by operating activities 75,302 84,616
Cash flows from investing activities    
Additions to property, plant, and equipment (8,901) (10,712)
Cash paid for equity method investment (447) 0
Proceeds from floor plan loans 0 1,606
Acquisition, net of cash acquired (24,555) 0
Proceeds from disposal of property, plant, and equipment 39 24
Net cash (used in) investing activities (33,864) (9,082)
Cash flows from financing activities    
Changes in floor plan financing, net (2,407) 1,573
Payments on long term debt (684) (1)
Payments for repurchase of common stock (50,000) (20,000)
Stock option exercises 3,550 75
Tax payments for equity-based compensation (2,323) (2,251)
Net cash (used in) financing activities (51,864) (20,604)
Effect of exchange rate changes on cash and cash equivalents 5,415 (1,060)
Net (decrease) increase in cash and cash equivalents (5,011) 53,870
Cash and cash equivalents at beginning of period 610,338 495,063
Cash and cash equivalents at end of period $ 605,327 $ 548,933